Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014;32(5):570-8.
doi: 10.1159/000360507. Epub 2014 Jul 14.

Update on the management of cholangiocarcinoma

Affiliations
Review

Update on the management of cholangiocarcinoma

J R A Skipworth et al. Dig Dis. 2014.

Abstract

Cholangiocarcinoma (CC) is a rare cancer arising from the epithelium of the biliary tree, anywhere from the small peripheral hepatic ducts to the distal common bile duct. Classification systems for CC typically group tumours by anatomical location into intrahepatic, hilar or extrahepatic subtypes. Surgical resection or liver transplantation remains the only curative therapy for CC, but up to 80% of patients present with advanced, irresectable disease. Unresectable CC remains resistant to many chemotherapeutic agents, although gemcitabine, particularly in combination with other agents, has been shown to improve overall survival. Ongoing investigation of biological agents has also yielded some promising results. Several novel interventional and endoscopic techniques for the diagnosis and management of non-operable CC have been developed: initial results show improvements in symptoms and progression-free survival, but further randomised studies are required to establish their role in the management of CC.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Disclosure Statement

Figures

Figure 1
Figure 1
Current algorithm for the management of indeterminate biliary strictures or suspected cholangiocarcinoma (Adapted from Skipworth et al [105]).

References

    1. Nakeeb A, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996;224(4):463–473. discussion 473-5. - PMC - PubMed
    1. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001;33(6):1353–1357. - PubMed
    1. Taylor-Robinson SD, et al. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998. Gut. 2001;48(6):816–820. - PMC - PubMed
    1. Endo I, et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg. 2008;248(1):84–96. - PubMed
    1. Khan SA, et al. Cholangiocarcinoma and its management. Gut. 2007;56(12):1755–1756. - PMC - PubMed

Publication types

MeSH terms